JP2023537474A5 - - Google Patents
Info
- Publication number
- JP2023537474A5 JP2023537474A5 JP2023507244A JP2023507244A JP2023537474A5 JP 2023537474 A5 JP2023537474 A5 JP 2023537474A5 JP 2023507244 A JP2023507244 A JP 2023507244A JP 2023507244 A JP2023507244 A JP 2023507244A JP 2023537474 A5 JP2023537474 A5 JP 2023537474A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- weeks
- intra
- betamethasone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061395P | 2020-08-05 | 2020-08-05 | |
| US63/061,395 | 2020-08-05 | ||
| PCT/US2021/044619 WO2022031898A1 (en) | 2020-08-05 | 2021-08-05 | Pharmaceutical composition of intra-articular corticosteroid for pain control |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023537474A JP2023537474A (ja) | 2023-09-01 |
| JP2023537474A5 true JP2023537474A5 (enExample) | 2024-07-09 |
Family
ID=77519828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507244A Pending JP2023537474A (ja) | 2020-08-05 | 2021-08-05 | 疼痛制御のための関節内コルチコステロイドの医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12514820B2 (enExample) |
| EP (1) | EP4192426A1 (enExample) |
| JP (1) | JP2023537474A (enExample) |
| KR (1) | KR20230048066A (enExample) |
| CN (1) | CN116348093A (enExample) |
| AU (1) | AU2021320774A1 (enExample) |
| BR (1) | BR112023001926A2 (enExample) |
| CA (1) | CA3187955A1 (enExample) |
| CL (1) | CL2023000315A1 (enExample) |
| IL (1) | IL300354A (enExample) |
| MX (1) | MX2023001410A (enExample) |
| TW (1) | TW202220668A (enExample) |
| WO (1) | WO2022031898A1 (enExample) |
| ZA (1) | ZA202301377B (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956600B2 (en) * | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
| BR112015000174A2 (pt) * | 2012-07-05 | 2017-06-27 | Taiwan Liposome Co Ltd | método para o tratamento da artrite |
| EP4389218A3 (en) * | 2017-03-14 | 2024-10-16 | Seikagaku Corporation | Composition for treating joint disease and kit containing same |
| EP3820479B1 (en) * | 2018-07-09 | 2026-03-11 | Taiwan Liposome Co., Ltd. | Methods to reduce complications of intra-articular steroid |
| IL281513B1 (en) | 2018-09-16 | 2026-07-01 | Tlc Biopharmaceuticals Inc | Preparations for the treatment of joint pain |
-
2021
- 2021-08-05 JP JP2023507244A patent/JP2023537474A/ja active Pending
- 2021-08-05 CN CN202180057600.XA patent/CN116348093A/zh active Pending
- 2021-08-05 BR BR112023001926A patent/BR112023001926A2/pt unknown
- 2021-08-05 KR KR1020237006338A patent/KR20230048066A/ko active Pending
- 2021-08-05 AU AU2021320774A patent/AU2021320774A1/en active Pending
- 2021-08-05 IL IL300354A patent/IL300354A/en unknown
- 2021-08-05 TW TW110128943A patent/TW202220668A/zh unknown
- 2021-08-05 WO PCT/US2021/044619 patent/WO2022031898A1/en not_active Ceased
- 2021-08-05 CA CA3187955A patent/CA3187955A1/en active Pending
- 2021-08-05 US US18/040,454 patent/US12514820B2/en active Active
- 2021-08-05 MX MX2023001410A patent/MX2023001410A/es unknown
- 2021-08-05 EP EP21762258.8A patent/EP4192426A1/en active Pending
-
2023
- 2023-02-01 CL CL2023000315A patent/CL2023000315A1/es unknown
- 2023-02-02 ZA ZA2023/01377A patent/ZA202301377B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6609286B2 (ja) | ヒトにおける炎症性障害の治療用リポソームコルチコステロイド | |
| Bateman et al. | Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma | |
| CN101048138B (zh) | 脂质体糖皮质激素用于治疗炎性状态的用途 | |
| US20030192533A1 (en) | New method | |
| Li et al. | Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma | |
| JP2007284452A (ja) | 新規な医薬組成物 | |
| EP2914722A1 (en) | Dosing and administration of oligonucleotide cancer therapies | |
| Nathan et al. | A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma | |
| TWI843751B (zh) | 適用於關節遞送的藥學組成物及其在治療關節疼痛上的用途 | |
| JP2020536859A5 (enExample) | ||
| TWI857961B (zh) | 減少關節內類固醇的併發症之方法 | |
| JP2022500364A5 (enExample) | ||
| Vastagh et al. | Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC | |
| TW201036616A (en) | Delayed-release glucocorticoid treatment of asthma | |
| TW201505635A (zh) | 治療潰瘍性結腸炎之方法 | |
| TW201212907A (en) | Inhaled combination product for asthma | |
| US20230285293A1 (en) | Pharmaceutical composition of intra-articular corticosteroid for pain control | |
| WO2025096949A1 (en) | Liposomal composition of intra-articular corticosteroid for pain control | |
| TW202320788A (zh) | 用於治療或預防抗宿主病的吡咯并六元雜芳物 | |
| NZ625022B2 (en) | Liposomal corticosteroids for treatment of inflammatory disorders in humans | |
| JP2007528889A (ja) | 吸入製剤 | |
| AU2013337298A1 (en) | Dosing and administration of oligonucleotide cancer therapies |